HomeMIRA • NASDAQ
add
Mira Pharmaceuticals Inc
Previous close
$1.06
Day range
$1.06 - $1.12
Year range
$0.73 - $2.45
Market cap
46.64M USD
Avg Volume
177.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.82M | 138.94% |
Net income | -5.98M | -149.34% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.03M | 289.35% |
Total assets | 11.09M | 279.52% |
Total liabilities | 702.07K | -2.94% |
Total equity | 10.39M | — |
Shares outstanding | 42.02M | — |
Price to book | 4.24 | — |
Return on assets | -155.52% | — |
Return on capital | -157.31% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -5.98M | -149.34% |
Cash from operations | -1.14M | 37.12% |
Cash from investing | — | — |
Cash from financing | 4.84M | 881.03% |
Net change in cash | 3.71M | 382.50% |
Free cash flow | -5.32M | -481.38% |
About
Founded
2020
Headquarters
Website
Employees
3
